UVA Health
Welcome,         Profile    Billing    Logout  
 16 Trials 
8 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jr, William N William
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
3
528
US
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet
Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex
Cataract
12/24
01/25
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed
3
571
Europe, Canada, US, RoW
NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel
NovoCure Ltd.
Pancreas Adenocarcinoma
10/24
10/24
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Completed
2
190
Canada, US
SUVN-G3031, Samelisant, Placebo
Suven Life Sciences Limited
Narcolepsy
06/23
06/23
GALAXIES LUNG-201, NCT05565378 / 2021-005115-32: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

Recruiting
2
340
Europe, Japan, US, RoW
Pembrolizumab, Dostarlimab, GSK4057190, Belrestotug, EOS884448, GSK4428859A, Nelistotug, GSK6097608
GlaxoSmithKline, iTeos Therapeutics
Lung Cancer, Non-Small Cell
10/25
10/28
QTX3544-201, NCT06715124: QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

Recruiting
1
237
US
QTX3544, Cetuximab
Quanta Therapeutics
Advanced Solid Tumors
01/27
01/29
Abbate, Antonio
MAVERIC-2, NCT06708299: CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation

Not yet recruiting
3
110
US
CardiolRx, Pharmaceutically produced cannabidiol
Cardiol Therapeutics Inc.
Recurrent Pericarditis
06/26
07/26
NCT05107934: Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis

Suspended
2/3
80
US
RPH-104, Placebo
R-Pharm Overseas, Inc., Data Management 365, Keystat, LLC
Recurrent Pericarditis
05/27
10/27
NCT06556810: IC14 for Treatment of Acute Decompensated Heart Failure

Recruiting
1/2
10
US
Atibuclimab (IC14), anti-CD14 monoclonal antibody
Implicit Bioscience, University of Virginia, Virginia Commonwealth University
Acute Decompensated Heart Failure
09/25
01/26
NAIK, BHIKEN
No trials found
Bardia, Amit
No trials found
Wang, Shuo
No trials found
Odackal, Namrita
No trials found
Sturek, Jeffery M
No trials found
Hogwood, Austin
No trials found
Shoemake, Rachel
No trials found

Download Options